Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?

Saved in:
Bibliographic Details
Main Authors: Gönczi Lóránt
Végh Zsuzsanna
Golovics Petra Anna
Rutka Mariann
Gecse Krisztina Barbara
Bor Renáta
Farkas Klaudia
Szamosi Tamás
Bene László
Gasztonyi Beáta
Kristóf Tünde
Lakatos László
Miheller Pál
Palatka Károly
Papp Mária
Format: Article
Published: 2017
Series:JOURNAL OF CROHNS & COLITIS 11 No. 6
doi:10.1093/ecco-jcc/jjw203

mtmt:3140312
Online Access:http://publicatio.bibl.u-szeged.hu/12011
Description
Physical Description:697-705
ISSN:1873-9946